HCPCS Level II · Miscellaneous services (temporary codes)
Q9979Injection, alemtuzumab, 1 mg
Terminated 12/31/2015
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About Q9979
Q9979 is an HCPCS Level II code in the Q series (miscellaneous services (temporary codes)), describing injection, alemtuzumab, 1 mg.
It was added to HCPCS effective 10/01/2015, and its current record took effect 01/01/2016.
It was terminated on 12/31/2015 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Injection, alemtuzumab
- Date added
- 10/01/2015
- Action effective
- 01/01/2016
- Termination date
- 12/31/2015
- BETOS
- O1E
Related Q99xx codes
- Q9950Injection, sulfur hexafluoride lipid microspheres, per ml
- Q9951Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9953Injection, iron-based magnetic resonance contrast agent, per ml
- Q9954Oral magnetic resonance contrast agent, per 100 ml
- Q9955Injection, perflexane lipid microspheres, per ml
- Q9956Injection, octafluoropropane microspheres, per ml
- Q9957Injection, perflutren lipid microspheres, per ml
- Q9958High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
- Q9959High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
- Q9960High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
- Q9961High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
- Q9962High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
Common questions about Q9979
Is HCPCS Q9979 still valid?
- No. Q9979 was terminated on 12/31/2015.
Does Medicare cover Q9979?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.